BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy - 2Senior's Manual for Obtaining a Hyundai Ioniq EV: Tips
- 3Role reversal: Ukraine moves training home and exports the lessons abroad
- 4Chevron Says Damage at Wheatstone LNG Will Hamper Restart
- 5Qantas and Virgin Australia Ban Power Bank Usage on Flights Following Safety Incidents
- I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions.
- Holiday weather forecast: Where travelers can expect a wintry mix, flooding and record warmth across the U.S.
- Watch interstellar comet 3I/ATLAS make its closest approach to Earth in free livestream on Dec. 18
- Venezuelan President Maduro arrives in New York following U.S. capture: Full coverage
- Comet MAPS faces a make-or-break moment as it dives toward the sun on April 4 — could it shine in the daytime sky?
- Mechanical Sidekick d: A Survey of \Elements and Execution d\ Cell phone
- Vote In favor of Your Number one Game Control center
- Nitty gritty Manual for Picking Agreeable Tennis shoes
- The Most Moving TED Talks You Want to Watch
